Report Detail

Pharma & Healthcare Dynamics in Post-pandemic Global Platelet-rich Plasma (PRP) Industry: Supply and Demand, Markets and Prices 2021-2027

  • RnM4311542
  • |
  • 13 April, 2021
  • |
  • Global
  • |
  • 133 Pages
  • |
  • GRD Survey
  • |
  • Pharma & Healthcare

Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Platelet-rich Plasma (PRP) market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Platelet-rich Plasma (PRP) market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

Segmented by Category
Pure PRP
Leucocyte-rich PRP
Leukocyte-rich Fibrin (L-PRF)

Segmented by End User/Segment
Orthopedic
Darmatology
Cardiac Muscle Injury
Dental
Nerve Injury
Others

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
Terumo
Arthrex
ISTO Biologics
EmCyte
REV-MED
DePuy Synthes
Regen Lab
Cesca Therapeutics
Weigao
Zimmer Biomet
Nuo Therapeutics


Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Platelet-rich Plasma (PRP) Market Status and Forecast (2016-2027)
      • 1.3.2 Global Platelet-rich Plasma (PRP) Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Platelet-rich Plasma (PRP) Supply by Company

    • 2.1 Global Platelet-rich Plasma (PRP) Sales Volume by Company
    • 2.2 Global Platelet-rich Plasma (PRP) Sales Value by Company
    • 2.3 Global Platelet-rich Plasma (PRP) Price by Company
    • 2.4 Platelet-rich Plasma (PRP) Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Platelet-rich Plasma (PRP) Market Status by Category

    • 3.1 Platelet-rich Plasma (PRP) Category Introduction
      • 3.1.1 Pure PRP
      • 3.1.2 Leucocyte-rich PRP
      • 3.1.3 Leukocyte-rich Fibrin (L-PRF)
    • 3.2 Global Platelet-rich Plasma (PRP) Market by Category
      • 3.2.1 Global Platelet-rich Plasma (PRP) Sales Volume by Category (2016-2021)
      • 3.2.2 Global Platelet-rich Plasma (PRP) Sales Value by Category (2016-2021)
      • 3.2.3 Global Platelet-rich Plasma (PRP) Price by Category (2016-2021)
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Platelet-rich Plasma (PRP) Market Status by End User/Segment

    • 4.1 Platelet-rich Plasma (PRP) Segment by End User/Segment
      • 4.1.1 Orthopedic
      • 4.1.2 Darmatology
      • 4.1.3 Cardiac Muscle Injury
      • 4.1.4 Dental
      • 4.1.5 Nerve Injury
      • 4.1.6 Others
    • 4.2 Global Platelet-rich Plasma (PRP) Market by End User/Segment
      • 4.2.1 Global Platelet-rich Plasma (PRP) Sales Volume by End User/Segment (2016-2021)
      • 4.2.2 Global Platelet-rich Plasma (PRP) Sales Value by End User/Segment (2016-2021)
      • 4.2.3 Global Platelet-rich Plasma (PRP) Price by End User/Segment (2016-2021)
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Platelet-rich Plasma (PRP) Market Status by Region

    • 5.1 Global Platelet-rich Plasma (PRP) Market by Region
      • 5.1.1 Global Platelet-rich Plasma (PRP) Sales Volume by Region
      • 5.1.2 Global Platelet-rich Plasma (PRP) Sales Value by Region
    • 5.2 North America Platelet-rich Plasma (PRP) Market Status
    • 5.3 Europe Platelet-rich Plasma (PRP) Market Status
    • 5.4 Asia Pacific Platelet-rich Plasma (PRP) Market Status
    • 5.5 Central & South America Platelet-rich Plasma (PRP) Market Status
    • 5.6 Middle East & Africa Platelet-rich Plasma (PRP) Market Status

    6 North America Platelet-rich Plasma (PRP) Market Status

    • 6.1 North America Platelet-rich Plasma (PRP) Market by Country
      • 6.1.1 North America Platelet-rich Plasma (PRP) Sales Volume by Country (2016-2021)
      • 6.1.2 North America Platelet-rich Plasma (PRP) Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Platelet-rich Plasma (PRP) Market Status

    • 7.1 Europe Platelet-rich Plasma (PRP) Market by Country
      • 7.1.1 Europe Platelet-rich Plasma (PRP) Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Platelet-rich Plasma (PRP) Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Platelet-rich Plasma (PRP) Market Status

    • 8.1 Asia Pacific Platelet-rich Plasma (PRP) Market by Country
      • 8.1.1 Asia Pacific Platelet-rich Plasma (PRP) Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Platelet-rich Plasma (PRP) Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Platelet-rich Plasma (PRP) Market Status

    • 9.1 Central & South America Platelet-rich Plasma (PRP) Market by Country
      • 9.1.1 Central & South America Platelet-rich Plasma (PRP) Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Platelet-rich Plasma (PRP) Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Platelet-rich Plasma (PRP) Market Status

    • 10.1 Middle East & Africa Platelet-rich Plasma (PRP) Market by Country
      • 10.1.1 Middle East & Africa Platelet-rich Plasma (PRP) Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Platelet-rich Plasma (PRP) Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Sales Channel, Distributors and Buyers

    • 11.1 Sales Channel
      • 11.1.1 Direct Sales
      • 11.1.2 Channel Sales
    • 11.2 Platelet-rich Plasma (PRP) Distributors
    • 11.3 Platelet-rich Plasma (PRP) Buyers

    12 Global Platelet-rich Plasma (PRP) Market Forecast by Category and by End User/Segment

    • 12.1 Global Platelet-rich Plasma (PRP) Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Platelet-rich Plasma (PRP) Forecast by Category
      • 12.2.1 Global Platelet-rich Plasma (PRP) Sales Volume Forecast by Category
      • 12.2.2 Global Platelet-rich Plasma (PRP) Sales Value Forecast by Category
      • 12.2.3 Global Platelet-rich Plasma (PRP) Price Forecast by Category
    • 12.3 Global Platelet-rich Plasma (PRP) Forecast by End User/Segment
      • 12.3.1 Global Platelet-rich Plasma (PRP) Sales Volume Forecast by End User/Segment
      • 12.3.2 Global Platelet-rich Plasma (PRP) Sales Value Forecast by End User/Segment
      • 12.3.3 Global Platelet-rich Plasma (PRP) Price Forecast by End User/Segment

    13 Global Platelet-rich Plasma (PRP) Market Forecast by Region/Country

    • 13.1 Global Platelet-rich Plasma (PRP) Market Forecast by Region (2022-2027)
      • 13.1.1 Global Platelet-rich Plasma (PRP) Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Platelet-rich Plasma (PRP) Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Terumo
      • 14.1.1 Company Information
      • 14.1.2 Platelet-rich Plasma (PRP) Product Introduction
      • 14.1.3 Terumo Platelet-rich Plasma (PRP) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 Contact Information
    • 14.2 Arthrex
      • 14.2.1 Company Information
      • 14.2.2 Platelet-rich Plasma (PRP) Product Introduction
      • 14.2.3 Arthrex Platelet-rich Plasma (PRP) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 Contact Information
    • 14.3 ISTO Biologics
      • 14.3.1 Company Information
      • 14.3.2 Platelet-rich Plasma (PRP) Product Introduction
      • 14.3.3 ISTO Biologics Platelet-rich Plasma (PRP) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 Contact Information
    • 14.4 EmCyte
      • 14.4.1 Company Information
      • 14.4.2 Platelet-rich Plasma (PRP) Product Introduction
      • 14.4.3 EmCyte Platelet-rich Plasma (PRP) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 Contact Information
    • 14.5 REV-MED
      • 14.5.1 Company Information
      • 14.5.2 Platelet-rich Plasma (PRP) Product Introduction
      • 14.5.3 REV-MED Platelet-rich Plasma (PRP) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 Contact Information
    • 14.6 DePuy Synthes
      • 14.6.1 Company Information
      • 14.6.2 Platelet-rich Plasma (PRP) Product Introduction
      • 14.6.3 DePuy Synthes Platelet-rich Plasma (PRP) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 Contact Information
    • 14.7 Regen Lab
      • 14.7.1 Company Information
      • 14.7.2 Platelet-rich Plasma (PRP) Product Introduction
      • 14.7.3 Regen Lab Platelet-rich Plasma (PRP) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 Contact Information
    • 14.8 Cesca Therapeutics
      • 14.8.1 Company Information
      • 14.8.2 Platelet-rich Plasma (PRP) Product Introduction
      • 14.8.3 Cesca Therapeutics Platelet-rich Plasma (PRP) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.8.4 Contact Information
    • 14.9 Weigao
      • 14.9.1 Company Information
      • 14.9.2 Platelet-rich Plasma (PRP) Product Introduction
      • 14.9.3 Weigao Platelet-rich Plasma (PRP) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.9.4 Contact Information
    • 14.10 Zimmer Biomet
      • 14.10.1 Company Information
      • 14.10.2 Platelet-rich Plasma (PRP) Product Introduction
      • 14.10.3 Zimmer Biomet Platelet-rich Plasma (PRP) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.10.4 Contact Information
    • 14.11 Nuo Therapeutics

    15 Conclusion

    Summary:
    Get latest Market Research Reports on Platelet-rich Plasma (PRP). Industry analysis & Market Report on Platelet-rich Plasma (PRP) is a syndicated market report, published as Dynamics in Post-pandemic Global Platelet-rich Plasma (PRP) Industry: Supply and Demand, Markets and Prices 2021-2027. It is complete Research Study and Industry Analysis of Platelet-rich Plasma (PRP) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,980.00
    $4,470.00
    $5,960.00
    2,381.02
    3,571.53
    4,762.04
    2,789.28
    4,183.92
    5,578.56
    468,992.40
    703,488.60
    937,984.80
    248,800.20
    373,200.30
    497,600.40
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report